Monopar Therapeutics Inc. presented new data on its drug candidate ALXN1840 (tiomolybdate choline) for Wilson disease at the European Association for the Study of the Liver International Liver ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results